Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Day One Biopharmaceuticals (DAWN) Other Working Capital Changes (2022 - 2025)

Day One Biopharmaceuticals (DAWN) has disclosed Other Working Capital Changes for 4 consecutive years, with -$974000.0 as the latest value for Q4 2025.

  • Quarterly Other Working Capital Changes fell 139.58% to -$974000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $253000.0 through Dec 2025, down 95.45% year-over-year, with the annual reading at $253000.0 for FY2025, 94.71% down from the prior year.
  • Other Working Capital Changes for Q4 2025 was -$974000.0 at Day One Biopharmaceuticals, down from -$480000.0 in the prior quarter.
  • The five-year high for Other Working Capital Changes was $3.1 million in Q3 2024, with the low at -$1.4 million in Q1 2023.
  • Average Other Working Capital Changes over 4 years is $372187.5, with a median of -$6500.0 recorded in 2023.
  • The sharpest move saw Other Working Capital Changes plummeted 230.81% in 2023, then surged 3080.77% in 2024.
  • Over 4 years, Other Working Capital Changes stood at -$567000.0 in 2022, then soared by 81.31% to -$106000.0 in 2023, then skyrocketed by 2421.7% to $2.5 million in 2024, then tumbled by 139.58% to -$974000.0 in 2025.
  • According to Business Quant data, Other Working Capital Changes over the past three periods came in at -$974000.0, -$480000.0, and $1.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.